Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone
2012 ◽
Vol 19
(1)
◽
pp. 215-224
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 4532-4532
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. 5081-5081
◽
2009 ◽
Vol 7
(2)
◽
pp. 407
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. 5017-5017
◽
2014 ◽
Vol 32
(5)
◽
pp. 1005-1016
◽